MedTrace Logo

Does Hip Strength Impact Active Females Rate of Pelvic Floor Dysfunction? The Primary Goal of This Research is to Collect Data on Hip Strength for Active Females and Assess if There is a Relationship Between Hip Strength and Pelvic Floor Dysfunction (PFD).

NCT07119476 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2025-08-13

No results posted yet for this study

Summary

The primary goal of this research is to collect data on hip strength for active females and assess if there is a relationship between hip strength and pelvic floor dysfunction (PFD). The participants will fill out a REDCap questionnaire that includes informed consent, demographics, injury history, history of PFD and/or hip pain, characteristics of physical activity and/or sport(s), knowledge of pelvic floor musculature, and questions regarding the correlation between PFD and performance. Additionally, Patient Reported Outcomes Measurement Information System (PROMIS) surveys assessing anxiety and depression will be included. After completing the questionnaires, a one time hip strength assessment will be performed in four directions on each hip and the evaluator will be blinded to their results. Foster et al researched hip and pelvic floor strength in a different patient population (Urgency and Frequency prominent lower urinary tract symptoms) in 2021 with 18-60 year olds and did not have a classification for level of physical activity. This research group found that there was a reduction in hip external rotation and abduction strength compared to case controls. To this point, there has not been any research assessing the relationship between hip strength and relaxing versus nonrelaxing pelvic floor dysfunction and controls.

Conditions

  • Pelvic Floor Muscle Weakness
  • Pelvic Floor Disorder
  • Pelvic Pain
  • Hip Strength

Sponsors & Collaborators

  • George Fox University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-11
Primary Completion
2025-02-24
Completion
2025-02-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07119476 on ClinicalTrials.gov